NasdaqGS - Delayed Quote USD

ImmunityBio, Inc. (IBRX)

Compare
5.30 -0.12 (-2.21%)
At close: November 7 at 4:00 PM EST
5.30 -0.00 (-0.00%)
After hours: 7:55 PM EST

Insider Purchases Last 6 Months

SharesTransactions
Purchases 0 0
Sales -- 0
Net Shares Purchased (Sold) 0 0
Total Insider Shares Held 536.59M --
% Net Shares Purchased (Sold) -- --

Net Institutional Purchases Prior Quarter to Latest Quarter

Shares
Net Shares Purchased (Sold) --
% Change in Institutional Shares Held --

Insider Transactions Reported - Last Two Years

InsiderTransactionTypeValueDate
ADCOCK RICHARD Chief Executive Officer -- Direct -- Feb 5, 2024
SIMON BARRY J. M.D. Director -- Direct -- Jan 31, 2024
SACHS DAVID C Chief Financial Officer -- Direct -- Jan 31, 2024
LAUER REGAN J Officer -- Direct -- Jan 31, 2024
ADCOCK RICHARD Chief Executive Officer -- Direct -- Dec 29, 2023
SACHS DAVID C Chief Financial Officer -- Direct -- Dec 29, 2023
LAUER REGAN J Officer -- Direct -- Dec 15, 2023
SIMON BARRY J. M.D. Director -- Direct -- Sep 1, 2023
SACHS DAVID C Chief Financial Officer -- Direct -- Sep 1, 2023
LAUER REGAN J Officer -- Direct -- Sep 1, 2023
LAUER REGAN J Officer -- Direct -- Jun 15, 2023
BLASZYK MICHAEL D Director Purchase at price 2.72 - 2.77 per share. Indirect 198,023 Jun 5, 2023
BRENNAN JOHN OWEN Director Purchase at price 2.74 - 2.90 per share. Direct 70,700 Jun 2, 2023
CLARK WESLEY K Director Purchase at price 2.91 per share. Direct 20,370 Jun 1, 2023
ADCOCK RICHARD Chief Executive Officer -- Direct -- Feb 3, 2023
ADCOCK RICHARD Chief Executive Officer -- Direct -- Dec 30, 2022
SACHS DAVID C Chief Financial Officer -- Direct -- Dec 30, 2022
SOON SHIONG PATRICK Officer, Director and Beneficial Owner Conversion of Exercise of derivative security at price 5.67 per share. Indirect 56,625,836 Dec 12, 2022

Related Tickers